<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
This filing relates to a regulatory compliance requirement under SEBI guidelines for entities classified as Large Corporates. The filing format is used to disclose details such as borrowings, asset cover, and other financial parameters. However, the actual document content is not available as the BSE page shows an error message indicating the page has been moved or is unavailable. The specific disclosure details for Bacil Pharma Ltd cannot be retrieved from the provided source.
Unable to assess impact as the actual filing data is not accessible. This appears to be a routine SEBI-mandated compliance filing for large corporates, which typically does not have direct immediate stock price implications.